NCT06490237

Brief Summary

The fine evaluation of the function of auditory neurons in silence and in noise in humans is difficult, if not impossible, to date with the conventional methods available. That is why in certain situations, the hearing aids of patient with hearing loss fail, especially in the presence of noise. In this study the investigators aim at investigating the global spontaneous and sound evoked human auditory nerve activity from electrophysiological acquisitions performed directly on the cochlear nerve in patients requiring posterior fossa surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
12mo left

Started Dec 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Dec 2021Jun 2027

First Submitted

Initial submission to the registry

August 3, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

December 7, 2021

Completed
2.6 years until next milestone

First Posted

Study publicly available on registry

July 8, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2027

Last Updated

July 8, 2024

Status Verified

June 1, 2024

Enrollment Period

5.5 years

First QC Date

August 3, 2021

Last Update Submit

July 3, 2024

Conditions

Keywords

Hearing LossDeafnessHearing Disorders in noise and in silenceEar Diseases

Outcome Measures

Primary Outcomes (2)

  • Compare the amplitude of global evoked auditory nerve activity

    Compare the amplitude and spectrum of global evoked auditory nerve activity in silence and in noise with basic and speech stimuli between patients defined as normo and hearing loss based on preoperative audiometric tests.

    66 months

  • Compare the spectrum of global evoked auditory nerve activity

    Compare the spectrum of global evoked auditory nerve activity in silence and in noise with basic and speech stimuli between patients defined as normo and hearing loss based on preoperative audiometric tests

    66 months

Secondary Outcomes (4)

  • Compare the difference of coding of the temporal envelope

    66 months

  • Compare the difference of coding of the fine structure

    66 months

  • Compare the two groups of investigation

    66 months

  • Compare the two groups of investigation

    66 months

Study Arms (2)

Subjects with no hearing loss

ACTIVE COMPARATOR
Procedure: near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode

subjects with hearing loss

EXPERIMENTAL
Procedure: near field recording of human auditory nerve activity during retro sigmoid approach with contact electrode

Interventions

During surgery using a retro-sigmoid approach in the cerebellopontine angle (microvascular decompression, vestibular neurotomy, meningioma or schwannoma removal), near-field recording of human auditory nerve activity using a contact electrode is performed on patients with normal or impaired hearing threshold. Each patient is explored preoperatively by hearing tests in noise and in silence. During the operation, stimuli are delivered in silence and in noise, under the same conditions as during the preoperative auditory exploration.

Subjects with no hearing losssubjects with hearing loss

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Will be included as hearing impaired patients:
  • male or female
  • over 18 years of age
  • who are to undergo surgery on the cerebellopontine angle (microvascular decompression, vestibular neurotomy, removal of a meningioma or schwannoma tumor)
  • with a mild to severe sensorineural hearing loss defined by an average hearing loss (average of thresholds obtained at 500, 1000, 2000 and 4000 Hz) greater than 20 dB and less than 90 dB in pure tone bone conduction audiometry on the side of the operated ear.
  • affiliated to a social security system.
  • have read the information note describing the study and have agreed in writing to participate by signing the informed consent form.
  • Will be included as normal hearing patients:
  • male or female
  • over 18 years of age
  • who are to undergo surgery in the cerebellopontine angle (microvascular decompression, vestibular neurotomy, removal of a meningioma or schwannoma tumor)
  • free of neuro-sensory deafness, defined by average hearing thresholds less than or equal to 20 dB in tonal bone conduction audiometry on the side of the operated ear
  • affiliated with a social security system.
  • having read the information note describing the study and having agreed in writing to participate by signing the informed consent form.

You may not qualify if:

  • Patients for whom the auditory nerve is not accessible during surgery,
  • because of a complete tumor invasion of the cochlear nerve (stage III and IV neuroma, advanced meningioma)
  • because of an anatomical feature not identified during the preoperative examination, making its exposure for recordings impossible (protrusion of the posterior face of the rock)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damien JOLLY

Reims, France

RECRUITING

MeSH Terms

Conditions

Hearing LossDeafnessEar Diseases

Condition Hierarchy (Ancestors)

Hearing DisordersOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2021

First Posted

July 8, 2024

Study Start

December 7, 2021

Primary Completion (Estimated)

June 7, 2027

Study Completion (Estimated)

June 7, 2027

Last Updated

July 8, 2024

Record last verified: 2024-06

Locations